https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: potential role in the diagnosis and management of prostate cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46813 Thu 01 Dec 2022 10:36:47 AEDT ]]> Prostate Cancer Radiotherapy: An Evolving Paradigm https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41252 Sat 30 Jul 2022 12:54:21 AEST ]]> Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7893 Sat 24 Mar 2018 10:44:59 AEDT ]]> Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10469 Sat 24 Mar 2018 08:09:12 AEDT ]]> Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29325 Sat 24 Mar 2018 07:34:20 AEDT ]]>